Preview
Unable to display preview. Download preview PDF.
References
Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA (1991a) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029–1032
Alexander HR, Doherty GM, Fraker DL, Block MI, Swedenborg JE, Norton JA (1991b) Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res 50:421–424
Ancuta P, Fahmi H, Pons JF, Le Blay K, Chaby R (1997) Involvement of the membrane form of tumour necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide. Immunology 92:259–266
Annenkov AY, Baranova FS (1991) Lipopolysaccharide-dependent and Lipopolysaccharide-independent pathways of monocyte desensitisation to Lipopolysaccharides. J Leukocyte Biol 50:215–222
Astiz ME, Galera A, Saha DC, Carpati C, Rackow EC (1994a) Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock 2:271–274
Astiz ME, Rackow EC, Still JG, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R, et al. (1995) Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med 23:9–17
Astiz ME, Saha DC, Carpati CM, Rackow EC (1994b) Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy. J Lab Clin Med 123:89–93
Atkins E (1960) Pathogenesis of fever. Physiol Rev 40:580–646
Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF (1998) Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 18:5678–5689
Balkhy HH, Heinzel FP (1999) Endotoxin fails to induce IFN-gamma in endotoxintolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J Immunol 162:3633–3638
Barsig J, Bundschuh DS, Hartung T, Bauhofer AM, Sauer A, and Wendel A (1996) Control of fecal peritoneal infection in mice by colony-stimulating factors. The Journal of Infectious Diseases 174:790–799
Basu S, Dunn AR, Marino MW, Savoia H, Hodgson G, Lieschke GJ, Cebon J (1997) Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 159:1412–1417
Bautista AP, Spitzer JJ (1995) Acute endotoxin tolerance downregulates superoxide anion release by the perfused liver and isolated hepatic nonparenchymal cells. Hepatology 21:855–862
Baykal A, Kaynaroglu V, Hascelik G, Sayek I, Sanac Y (1999) Epinephrine and endotoxin tolerance differentially modulate serum cytokine levels to high-dose lipopolysaccharide challenge in a murine model. Surgery 125:403–410
Beeson PB (1946) Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med 61:248–250
Beeson PB (1947) Tolerance to bacterial pyrogens. J Exp Med 86:29–44
Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339–2347
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977–980
Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871
Blackwell TS, Blackwell TR, Christman JW (1997) Impaired activation of nuclear factor-kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 158:5934–5940
Boehme D, Dubos RJ (1956) The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system. J Exp. Med. 107:523–536
Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C (1993) Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages. J Immunol 151:301–309
Bohlinger I, Leist M, Barsig J, Uhlig S, Tiegs G, Wendel A (1995) Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology 22:1829–1837
Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ (1998) Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 102:1645–1652
Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125–1128
Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–243
Bowling WM, Hafenrichter DG, Flye MW, Callery MP (1995) Endotoxin tolerance alters phospholipase C-gamma 1 and phosphatidylinositol-3′-kinase expression in peritoneal macrophages. J Surg Res 58:592–598
Bundschuh DS (1997) Immunomodulation in murine models of the systemic inflammatory response syndrome. Doktorarbeit an der Universität Konstanz.
Bundschuh DS, Barsig J, Hartung T, Randow F, Döcke WD, Volk HD, and Wendel A (1997) Granulocyte-Macrophage Colony-Stimulating Factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol 158:2862–2871
Burrell R (1994) Human responses to bacterial endotoxin. Circulatory Shock 43:137–153
Busam KJ, Schulze-Specking A, Decker K (1991) Endotoxin-refractory liver macrophages secrete tumor necrosis factor-alpha upon viral infection. Biol Chem Hoppe Seyler 372:157–162
Butler RC, Abdelnoor AM, Nowotny A (1978) Bone marrow colony-stimulating factor and tumor resistence-enhancing activity of postendotoxin mouse sera. Proc Natl Acad Sci 75:2893–2896
Butler RC, Nowotny A (1976) Colony stimulating factor (CSF)-containing serum has anti-tumor effects. IRCS Medical Science 4:206
Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M, Ryffel B (1994) Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437–1444
Cavaillon J-M (1995) The nonspecific nature of endotoxin tolerance. Trends Microbiol 3:320–324
Cavaillon JM, Munoz C, Marty C, Cabie A, Tamion F, Misset B, Carlet J, Fitting C (1993) Cytokine production by monocytes from patients with sepsis syndrome and by endotoxin-tolerant human monocytes. In: Levein J, Alving CR, Munford RS, Stütz PL (eds) Bacterial endotoxin: Recognition and effector mechanisms. Elsevier Science Publisher B.V., pp. 275–286
Cavaillon J-M, Pitton C, Fitting C (1994) Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10, and TGFb. J Endotoxin Res 1:21–29
Centanni E (1894) Untersuchungen über das Infectionsfieber—das Fiebergift der Bacterien. Dtsch. Med. Wochenschr. 20:148–150
Centanni E (1942) Immunitätserscheinungen im experimentellen Fieber mit besonderer Berücksichtigung des pyrogenen Stoffes aus Typhusbakterien. Klin. Wochenschr. 21:664–669
Chamulitrat W, Wang JF, Spitzer JJ (1995) Electron paramagnetic resonance investigations of nitrosyl complex formation during endotoxin tolerance. Life Sci 57:387–395
Chang CC, McCormick CC, Lin AW, Dietert RR, Sung YJ (1996) Inhibition of nitric oxide synthase gene expression in vivo and in vitro by repeated doses of endotoxin. Am J Physiol 271:G539–548
Chang H, Thompson JJ, Nowotny A (1974) Release of colony stimulating factor (CSF) by non-endotoxic breakdown products of bacterial lipopolysaccharides. Immunol Commun 3:401–409
Chautard T, Spinedi E, Voirol M, Pralong FP, Gaillard RC (1999) Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration. Neuroendocrinology 69:360–369
Chedid L, Parant M, Boyer F, Skarnes RC (1964) Nonspecific host responses in tolerance to the lethal effect of endotoxins. In: Landy M, Braun W (eds) Bacterial Endotoxin. Rutgers University Press, New Brunswick, NJ, pp 500–516
Coelho MM, Luheshi G, Hopkins SJ, Pela IR, Rothwell NJ (1995) Multiple mechanisms mediate antipyretic action of glucocorticoids. Am J Physiol 269:R527–535
Coffee KA, Halushka PV, Ashton SH, Tempel GE, Wise WC, Cook JA (1992) Endotoxin tolerance is associated with altered GTP-binding protein function. J Appl Physiol 73:1008–1013
Cross A, Asher L, Seguin M, Yuan L, Kelly N, Hammack C, Sadoff J, Gemski P, Jr. (1995) The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J Clin Invest 96:676–686
Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P (1989) Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J Exp Med 169:2021–2027
Dai WJ, Bartens W, Kohler G, Hufnagel M, Kopf M, Brombacher F (1997) Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J Immunol 158:5297–5304
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220
Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321S–329S
Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503–508
Dinarello CA, Bodel PT, Atkins E (1968) The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc Am Physicians 81:334–344
Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678–681
Dubos RJ, Schaedler RW (1956) Reversible changes in the susceptibility of mice to bacterial infections. J. Exp. Med. 104:53–65
Dubos RJ, Schaedler RW (1957) Effects of cellular constituents of mycobacteria on the resistance of mice to hererologous infections. J. Exp. Med. 106:703–717
Erroi A, Fantuzzi G, Mengozzi M, Sironi M, Orencole SF, Clark BD, Dinarello CA, Isetta A, Gnocchi P, Giovarelli M, Giovarelli M, Ghezzi P (1993) Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect Immun 61:4356–4359
Ertel W, Kremer J-P, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341–1347
Evans GF, Zuckerman SH (1991) Glucocorticoid-dependent and-independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol 21:1973–1979
Faggioni R, Fantuzzi G, Villa P, Buurman W, van Tits LJ, Ghezzi P (1995) Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun 63:1473–1477
Fahmi H, Chaby R (1993) Selective refractoriness of macrophages to endotoxin-induced production of tumor necrosis factor, elicited by an autocrine mechanism. J Leukoc Biol 53:45–52
Favorite GO, Morgan HR (1942) Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella thyphosa: clinical, hematological, chemical and serological studies. J. Clin. Invest. 21:589–599
Feterowski C, Weighardt H, Emmanuilidis K, Hartung T, Holzmann B (2001) Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur. J. Immunol. in press
Flach R, Schade FU (1997) Peritoneal macrophages from endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor alpha synthesis and protect against endotoxin shock. J. Endotoxin Res. 4:241–250
Flohe S, Dominguez Fernandez E, Ackermann M, Hirsch T, Borgermann J, Schade FU (1999) Endotoxin tolerance in rats: expression of TNF-alpha, IL-6, IL-10, VCAM-1 AND HSP 70 in lung and liver during endotoxin shock. Cytokine 11:796–804
Fraker DL, Stovroff MC, Merino MJ, Norton JA (1988) Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 168:95–105
Frankenberger M, Pechumer H, Ziegler-Heitbrock HW (1995) Interleukin-10 is upregulated in LPS tolerance. J Inflamm 45:56–63
Freedman HH (1960a) Further studies on passive transfer of tolerance to pyrogenicity of bacterial endotoxin. J. Exp. Med. 112:619–634
Freedman HH (1960b) Passive transfer of tolerance to pyrogenicity of bacterial endotoxin. J. Exp. Med. 111:453–463
Freudenberg MA, Galanos C (1988) Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 56:1352–1357
Freudenberg MA, Keppler D, Galanos C (1986) Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun 51:891–895
Gahring LC, Daynes RA (1986) Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance. J Immunol 136:2868–2874
Galanos C, Freudenberg MA (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346–356
Galdiero M, Marcatili A, Cipollaro de l'Ero G, Nuzzo I, Bentivoglio C, Romano Carratelli C (1999) Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice. Infect Immun 67:1432–1438
Galelli A, Parant M, Chedid L (1977) Role of radiosensitive and radioresistant cells in nonspecific resistance to infection of LPS-treated mice. J Reticuloendothel Soc 21:109–118
Geller P, Merril ER, Jawetz E (1954) Effects of cortisone and antibioticx on the lethal action of endotoxins in mice. Proc Soc Exp Biol Med 86:716–725
Goujon E, Parnet P, Laye S, Combe C, Dantzer R (1996) Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res Mol Brain Res 36:53–62
Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, Ye K, Vanier E, Wolff SM, Dinarello CA (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151:1637–1645
Greisman SE, Wagnr HN, Iio M, Hornick RB (1964) Mechanisms of endotoxin tolerance. II. Relationship between endotoxin and reticuloendothelial system phagocytic activity in man. J Exp Med 119:241–264
Greisman SE, Young EJ, Carozza FA, Jr. (1969) Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J Immunol 103:1223–1236
Greisman SE, Young EJ, Woodward WE (1966) Mechanisms of endotoxin tolerance. IV. Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin. J Exp Med 124:983–1000
Gustafson GL, Rhodes MJ, Hegel T (1995) Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog Clin Biol Res 392:567–579
Haas JG, Baeuerle PA, Riethmuller G, Ziegler-Heitbrock HW (1990) Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci USA 87:9563–9567
Hafenrichter DG, Roland CR, Mangino MJ, Flye MW (1994) The Kupffer cell in endotoxin tolerance: mechanisms of protection against lethal endotoxemia. Shock 2:251–256
Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C (1984) Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46:839–844
Hamilton-Davies C, Webb AR (1995) Monophosphoryl lipid A and endotoxin tolerance [letter]: Crit Care Med 23:1789–1790
Hartung T, Wendel A (1992) Endotoxin-inducible cytotoxicity in liver cell cultures. II. Demonstration of endotoxin-tolerance. Biochem Pharmacol 43:191–196
Haslberger A, Sayers T, Reiter H, Chung J, Schutze E (1988) Reduced release of TNF and PCA from macrophages of tolerant mice. Circ Shock 26:185–192
He W, Fong Y, Marano MA, Gershenwald JE, Yurt RW, Moldawer LL, Lowry SF (1992) Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine response. J Infect Dis 165:859–864
Heagy W, Hansen C, Nieman K, Rodriguez JL, West MA (2000) Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J Trauma 49:806–814
Hebert JC, O'Reilly M (1996) Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy. J Trauma 41:663–666
Hebert JC, O'Reilly M, Barry B, Shatney L, Sartorelli K (1997) Effects of exogenous cytokines on intravascular clearance of bacteria in normal and splenectomized mice. J Trama 43:875–879
Hebert JC, O'Reilly M, Gamelli RL (1990) Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 125:1075–1078
Hebert JC, O'Reilly M, Yuenger K, Shatney L, Yoder DW, Barry B (1994) Augmentation of alveolar macrophage phagocytic activity by granulocyte colony stimulating factor and interleukin-1: influence of splenectomy. J Trauma 37:909–912
Henriscon BE, Benjamin WR, Vogel SN (1990) Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect Immun 58:2429–2437
Henricson BE, Neta R, Vogel SN (1991) An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun 59:1188–1191
Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC, Jr. (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204–207
Hill AW, Hibbitt KG, Shears A (1974) Endotoxin tolerance and the induction of nonspecific resistance to Salmonella dublin and Streptococcus agalactiae infections in mice. Br J Exp Pathol 55:269–274
Hirohashi N, Morrison DC (1996) Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun 64:1011–1015
Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749–3752
Howard JG, Rowley D, and Wardlay AC (1958) Immunology 1:181–203
Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205–1208
Irikura VM, Hirsch E, Hirsh D (1999) Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes. Infect Immun 67:1901–1909
Johnston CA, Greisman SE (1985) Mechanism of endotoxin tolerance. In: Hinshaw IB (ed). Elsevier Science Publishers, pp 359 bis 401 (Handbook of Endotoxin
Kagaya K, Watanabe K, Fukazawa Y (1989) Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect Immun 57:609–615
Kanthack AA (1892) Acute leukocytosis produced by bacterial products. Br. Med. J. 1:1301–1303
Kaplan E, Dinarello CA, Wakabayashi G, Burke JF, Connolly RS, Gelfand JA (1993) Interleukin-1 pretreatment protects against endotoxin-induced hypotension in rabbits: association with decreased tumor necrosis factor levels. J Infect Dis 167:244–247
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G (1998) Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28:3128–3136
Kastenbauer S, Ziegler-Heitbrock HW (1999) NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun 67:1553–1559
Kiani A, Tschiersch A, Gaboriau E, Otto F, Seiz A, Knopf HP, Stutz P, Farber L, Haus U, Galanos C, Mertelsmann R, Engelhardt R (1997) Downregulation of the pro-inflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients. Blood 90:1673–1683
Kimmings AN, Pajkrt D, Zaajer K, Moojen TM, Meenan JK, ten Cate JW, van Deventer SJH (1996) Factors involved in early in vitro endotoxin hyporesponsiveness in human endotoxemia. J Endotoxin Res 3:283–289
Kiser JS, Lindh H, de Mello GC (1956) The effect of various substances on resistance to experimental infections. Ann NY Acad Sci 66:312–327
Klosterhalfen B, Horstmann-Jungemann K, Vogel P, Flohe S, Offner F, Kirkpatrick CJ, Heinrich PC (1992) Time course of various inflammatory mediators during recurrent endotoxemia. Biochem Pharmacol 43:2103–2109
Knopf HP, Otto F, Engelhardt R, Freudenberg MA, Galanos C, Herrmann F, Schumann RR (1994) Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down-regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression. J Immunol 153:287–299
Kox WJ, Bone RC, Krausch D, Docke WD, Kox SN, Wauer H, Egerer K, Querner S, Asadullah K, von Baehr R, Volk HD (1997) Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med 157:389–393
Kraatz J, Clair L, Bellingham J, Wahlstrom K, Rodriguez JL, West MA (1998) Lipopolysaccharide pretreatment produces macrophage endotoxin tolerance via a serum-independent pathway. J Trauma 45:684–691
Kraatz J, Clair L, Rodriguez JL, West MA (1999b) In vitro macrophage endotoxin tolerance: defective in vitro macrophage map kinase signal transduction after LPS pretreatment is not present in macrophages from C3H/Hej endotoxin resistant mice. Shock 11:58–63
Kraatz J, Clair L, Rodriguez JL, West MA (1999b) Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J Surg Res 83:158–164
Kreutz M, Ackermann U, Hauschildt S, Krause SW, Riedel D, Bessler W, Andreesen R (1997) A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes. Immunology 92:396–401
Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380–5384
Labeta MO, Durieux JJ, Spagnoli G, Fernandez N, Wijdenes J, Herrmann R (1993) CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology 80:415–423
Lam C, Schutze E, Hildebrandt J, Aschauer H, Liehl E, Macher I, Stutz P (1991a) SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis. Antimicrob Agents Chemother 35:500–505.
Lam C, Schutze E, Liehl E, Stutz P (1991b) Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone. Antimicrob Agents Chemother 35:506–511
Landy M, and Pillemer L (1956) Increased resistance to infection and accompanying alteration in properdin levels following administration of bacterial lipopolysacharides. J Exp Med 104:383–409
Lange JR, Alexander HR, Merino MJ, Doherty GM, Norton JA (1992) Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis. J Surg Res 52:555–559
Langermans JAM, van Furth R (1994) Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium. Biotherapy 7:169–178
Larsen NE, Sullivan R (1984) Interaction between endotoxin and human monocytes characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci U S A 81:3491–3495
LaRue KE, McCall CE (1994) A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med 180:2269–2275
Learn CA, Mizel SB, McCall CE (2000) mRNA and protein stability regulate the differential expression of pro-and anti-inflammatory genes in endotoxin-tolerant THP-1 cells. J Biol Chem 275:12185–12193
Lehner MD, Ittner J, Bundschuh DS, van Rooijen N, Wendel A, Hartung T (2001a) Improved innate immunity of endotoxin-tolerant mice increases resistance to salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun 69:463–471
Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T (2001b) Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol 166:5161–5167
Leon P, Redmond HP, Shou J, Daly JM (1992) Interleukin 1 and relationship to endotoxin tolerance. Arch Surg 127:146–151
Lepe-Zuniga JL, Klostergaard J (1990) Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes. Lymphokine Res 9:309–319
Li L, Cousart S, Hu J, McCall CE (2000) Characterization of interleukin-1 receptor-association kinase in normal and endotoxin-tolerant cells. J Biol Chem 275:23340–23345
Li MH, Seatter SC, Manthei R, Bubrick M, West MA (1994) Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res 57:85–92
Libert C, Van Bladel S, Brouckaert P, Shaw A, Fiers W (1991) Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J Immunol 146:2625–2632
Libert C, Van Molle W, Brouckaert P, Fiers W (1996) alphal-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 157:5126–5129
MacGregor RR, Sheagren JN, Wolff SM (1969) Endotoxin-induced modification of Plasmodium berghei infection in mice. J Immunol 102:131–139
Mackensen A, Galanos C, Engelhardt R (1991) Modulating activity of interferongamma on endotoxin-induced cytokine production in cancer patients. Blood 78:3254–3258
Mackensen A, Galanos C, Wehr U, Engelhardt R (1992) Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw 3:571–579
Madonna GS, Peterson JE, Ribi EE, Vogel SN (1986) Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect Immun 52:6–11
Madonna GS, Vogel SN (1985) Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J Immunol 135:3763–3771
Madonna GS, Vogel SN (1986) Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice. Infect Immun 53:707–710
Makhlouf M, Zingarelli B, Halushka PV, Cook JA (1998a) Endotoxin tolerance alters macrophage membrane regulatory G proteins. Prog Clin Biol Res 397:217–226
Makhlouf MA, Fernando LP, Gettys TW, Halushka PV, Cook JA (1998b) Increased prostacyclin and PGE2 stimulated cAMP production by macrophages from endotoxin-tolerant rats. Am J Physiol 274:C1238–1244
Marik PE, Varon J (1998) The hemodynamic derangements in sepsis: implications for treatment strategies. Chest 114:854–860
Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, Okamura H, Kurimoto M, Dougan G (1999) Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 67:478–483
Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ (1990) Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 85:1108–1118
Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81:1925–1937
Matic M, Simon SR (1991) Tumor necrosis factor release from lipopolysaccharidestimulated human monocytes: lipopolysaccharide tolerance in vivo. Cytokine 3:576–583
Matic M, Simon SR (1992) Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infect Immun 60:3756–3762
Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S (1994a) Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 179:1671–1676
Matsuura M, Kiso M, Hasegawa A, Nakano M (1994b) Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumornecrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms. Eur J Biochem 221:335–341
McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL (1993) Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91:853–861
Medvedev AE, Kopydlowski KM, Vogel SN (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164:5564–5574
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2:253–258
Mengozzi M, Fantuzzi G, Sironi M, Fratelli M, Peri G, Bernasconi S, Ghezzi P (1993) Early down regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1, IL-6, and IL-8 Lympho Cyt Res 12:231–236
Mengozzi M, Sironi M, Gadina M, Ghezzi P (1991) Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J Immunol 147:899–902
Moore JN, Cook JA, Morris DD, Halushka PV, Wise WC (1990) Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis, factor produc-tion by rat peritoneal macrophages: effect of endotoxin tolerance and glucan. Circ Shock 31:281–295.
Moreau SC, Skarnes RC (1973) Host resistence to bacterial endotoxemia: mechanisms in endotoxin-tolerant animals. J Infect Dis 128:122–133
Morikage T, Mizushima Y, Sakamoto K, Yano S (1990) Prevention of fatal infections by recombinant human interleukin 1 alpha in normal and anticancer drugtreated mice. Cancer Res 50:2099–2104
Morrissey PJ, Charrier K (1994) Treatment of mice with IL-1 before infection increases resistence to a lethal challenge with salmonella typhimurium. J Immunol 153:212–219.
Morrissey PJ, Charrier K, Vogel, S.N. (1995) Exogenous tumor necrosis factor alpha and interleukin-1 a increase resistance to salmonella typhimurium: efficacy is influenced by the ity and lps loci. Infect Immun 63:3196–3198
Morrow LE, McClellan JL, Conn CA, Kluger MJ (1993) Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am J Physiol 264:R1010–1016
Munoz C, Carlet J, Fitting C, Misset B, Bleriot J-P, Cavaillon J-M (1991) Dysregulation of in vitro cytokine response by monocytes during sepsis. J Clin Invest 88:1747–1754
Nakano M, Onozuka K, Saito-Taki T (1984) LPS-induced non-specific resistance to immunodefective CBA/N mice against Salmonella infection Immunopharmacology of Endotoxicosis. Walther de Gruyter and Co., Berlin, pp. 115–132.
Nakano M, Onozuka K, Yamasu H, Zhong WF, Nakano Y (1992) Protective effects of cytokines in murine Salmonellosis. In: Friedman Hea (ed) Microbial Infections. Plenum Press, New York, pp 89–95 (Microbial. Infections)
Nakano Y, Onozuka K, Terada Y, Shinomiya H, and Nakano M (1990) Protective effect of recombinant tumor necrosis factor alpha in murine salmonellosis. J Immunol 144:1935–1941
Nauciel C, Espinasse-Maes F (1992) Role of gamma interferon and tumor necrosis factor alpha in resistance to salmonella typhimurium infection. Infect Immun 60:450–454
Neviere RR, Cepinskas G, Madorin WS, Hoque N, Karmazyn M, Sibbald WJ, Kvietys PR (1999) LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes. Am J Physiol 277:H885–892
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476–3479
Nowotny A, Behling UH (1982) Studies on host defenses enhanced by endotoxins: a brief review. Klinische Wochenschrift 60:735–739.
O'Brien DP, Briles DE, Szalai AJ, Tu AH, Sanz I, Nahm MH (1999) Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections. Infect Immun 67:595–601.
Ogle CK, Guo X, Chance WT, Ogle JD (1997) Induction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor. Crit Care Med 25:827–833
Onozuka K, Shimada S, Yamasu H, Osada Y, Nakano M (1993) Non-specific resistance induced by a low-toxic lipid A analogue, DT-5461, in murine salmonellosis. Int J Immunopharmacol 15:657–664
O'Reilly M, Silver GM, Davis JH, Gamelli RL, Hebert JC, (1992a) Interleukin 1 beta improves survival following cecal ligation and puncture. J Surg Res 52:518–522
O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC (1992b) Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 33:679–682
Ozmen Le (1994) Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med 180:907–915
Pannell L (1956a) Studies on protection against experimental tularemia in mice I. J Infect Dis 102:162–166
Pannell L (1956b) Studies on protection against experimental tularemia in mice II. J Infect Dis 102:167–173
Parant M (1968) [Study of opsonins in mice after endotoxin augmentation of their resistance to infection]. Ann Inst Pasteur (Paris) 115:264–278
Parant M (1980) Antimicrobial resistance enhancing activity of tumor necrosis serum factor induced by endotoxin in BCG-treated mice. Recent Results Cancer Res 75:213–219
Parant M, Chedid L (1971) [Sensitization of mice to endotoxins by adrenalectomy or by administration of actinomycin D]. C R Acad Sci Hebd Seances Acad Sci D 272:1308–1311
Parant M, Galelli A, Parant F, Chedid L (1976) Role of B-lymphocytes in nonspecific resistance to Klebsiella pneumoniae infection of endotoxin-treated mice. J Infect Dis 134:531–539
Parant MA, Parant FJ, Chedid LA (1980) Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice. Infect Immun 28:654–659
Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW, (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457–467
Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088
Quesenberry P, Halperin J, Ryan M, Stohlman F (1975) Tolerance to the granulocyte-releasing and colony-stimulating factor elevating effects of endotoxin. Blood 45:789–800.
Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D (1999) Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615–625
Randow F, Döcke WD, Bundschuh DS, Hartung T, Wendel A, and Volk HD (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN gamma, IL-12, and Granulocyte-Macrophage Colony Stimulating Factor. J Immunol 158:2911–2918
Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181:1887–1892
Rayhane N, Fitting C, Lortholary O, Dromer F, Cavaillon JM (2000) Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun 68:3748–3753
Renz H, Gong JH, Schmidt A, Nain M, Gemsa D (1988) Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 141:2388–2393
Riedel DD, Kaufmann SH (2000) Differential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages. Microbes Infect 2:463–471
Rodrick ML, Moss NM, Grbic JT, Revhaug A, O'Dwyer ST, Michie HR, Gough DB, Dubravec D, Manson JM, Saporoschetz IB, et al. (1992) Effects of in vivo endotoxin infusions on in vitro cellular immun responses in humans. J Clin Immunol 12:440–450
Rogers TS, Halushka PV, Wise WC, Cook JA (1986) Differential alteration of lipoxygenase and cyclooxygenase metabolism by rat peritoneal macrophages induced by endotoxin tolerance. Prostaglandins 31:639–650
Rogers TS, Halushka PV, Wise WC, Cook JA (1989) Arachidonic acid turnover in peritoneal macrophages is altered in endotoxin-tolerant rats. Biochim Biophys Acta 1001:169–175
Roth J, Aslan T, Storr B, Zeisberger E (1997) Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-alpha and IL-6 in guinea pigs. Am J Physiol 273:R1529–1533
Roth J, Zeisberger E (1995) Endotoxin tolerance alters thermal response of guinea pigs to systemic infusions of tumor necrosis factor-alpha. Am. J. Physiol. 268:514–519
Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798–802
Rowley D (1955) Stimulation of natural immunity to Escherichia coli infections. The Lancet 1:232
Rowley D (1956) Rapidly induced changes in the level of nonspecific immunity in laboratory animals. Brit. J. Exp. Path. 37:233
Rowley D (1960) The role of opsonins in non-specific immunity. J. Exp. Med. 111:137–144
Rudbach JA, Myers KR, Rechtman DJ, Ulrich JT (1994) Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis. Prog Clin Biol Res 388:107–124
Ruggiero G, Andreana A, Utili R, Galante D (1980) Enhanced phagocytosis and bactericidal activity of hepatic reticuloendothelial system during endotoxin tolerance. Infect Immun 27:798–803
Rumpf T (1893) Die Behandlung des Typhus ab dominalis mit abgetödteten Culturen des Bacillus pyocyaneus. Dtsch. Med. Wchnschr. 19:987–989
Salkowski CA, Detore G, Franks A, Falk MC, Vogel SN (1998) Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun 66:3569–3578
Sanchez-Cantu L, Rode HN, Christou NV (1989) Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 124:1432–1435; discussion 1435–1436
Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S (2000) Synergy and cross-tolerance between toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J Immunol 165:7096–7101
Scales WE, Chensue SW, Otterness I, Kunkel SL (1989) Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. J Leukoc Biol 45:416–421
Schade F, Schlegel J, Hofman K, Brade H, Flach R (1996) Endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor synthesis. J. Endotoxin Res. 3:455–462
Schutze E, Hildebrandt J, Liehl E, Lam C (1994) Protection of mice from mortality caused by living and heat-killed bacteria by SDZ MRL 953. Circ Shock 42:121–127
Seatter SC, Li MH, Bubrick MP, West MA (1995) Endotoxin pretreatment of human monocytes alters subsequent endotoxin-triggered release of inflammatory mediators. Shock 3:252–258
Serushago BA, Yoshikai Y, Handa T, Mitsuyama M, Muramori K, Nomoto K (1992) Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistence against Listeria monocytogenes. Immunol 75:475–480
Severn A, Xu D, Doyle J, Leal LM, O'Donnell CA, Brett SJ, Moss DW, Liew FY (1993) Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. Eur J Immunol 23:1711–1714
Shilo M (1959) Nonspecific resistance to infections. Ann Rev Microbiol 13:255–278
Shimauchi H, Ogawa T, Okuda K, Kusumoto Y, Okada H (1999) Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes. Infect Immun 67:2153–2159
Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR (1996) Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 157:360–368
Steer JH, Kroeger KM, Abraham LJ, Joyce DA (2000) Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem 275:18432–18440
Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR (1994) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A 91:271–275
Takano M, Yokoyama K, Yayama K, Itoh N, Okamoto H (1993), Endotoxin-induced enhancement of angiotensinogen synthesis in the liver: decreased response following repeated endotoxin exposure. Biol Pharm Bull 16:917–920
Takasuka N, Matsuura K, Yamamoto S, Akagawa KS (1995) Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. J Immunol 154:4803–4812
Takasuka N, Tokunaga T, Akagawa KS (1991) Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA. J Immunol 146:3824–3830
Tiegs G, Barsig J, Matiba B, Uhlig S, Wendel A (1994) Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest 93:2616–2622
Tite JP, Dougan G, Chatfield SN (1991) The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol 147:3161–3164
Tominaga K, Saito S, Matsuura M, Nakano M (1999) Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-kappaB cascades, but not lipopolysaccharide-incorporation steps. Biochim Biophys Acta 1450:130–144.
Tully JG, Gaines S, Tigertt WD (1965) Studies on infection and immunity in experimental typhoid fever. VI. Response of chimpanzees to endotoxin and the effect of tolerance on resistance to oral challenge. J Infect Dis 115:445–455
Urbaschek B, Ditter B, Becker KP, Urbaschek R (1984) Protective effects and role of endotoxin in experimental septicemia. Circ Shock 14:209–222
Urbaschek R, Urbaschek B (1985) Induction of nonspecific resistance and stimulation of granulopoiesis by endotoxins and nontoxic bacterial cell wall components and their passive transfer. Ann NY Acad Sci 459:97–110
van Furth R, van Zwet TL, Buisman AM, and van Dissel JT (1994) Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs. J. Inf. Dis. 170:234–237
Van Molle W, Denecker G, Rodriguez I, Brouckaert P, Vandenabeele P, Libert C (1999) Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 163:5235–5241
Van Molle W, Libert C, Fiers W, Brouckaert P (1997) Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 159:3555–3564
Villa P, Shaklee CL, Meazza C, Agnello D, Ghezzi P, Senaldi G (1998) Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J Infect Dis 178:471–477
Virca GD, Kim SY, Glaser KB, Ulevitch RJ (1989) Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem 264:21951–21956
Vogel SN, Johnson D, Perera PY, Medvedev A, Lariviere L, Qureshi ST, Malo D (1999) Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J Immunol 162:5666–5670
Vogel SN, Kaufman EN, Tate MD, Neta R (1988) Recombinant interleukin-1a and recombinant tumor necrosis factor a synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 56:2650–2657
Vogels MT, Eling WM, Otten A, van der Meer JW (1995) Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor. Antimicrob Agents Chemother 39:1744–1747
Vogels MT, Hermsen CC, Huys HL, Eling EM, van der Meer JW (1994a) Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun 62:2065–2070
Vogels MT, Mensink EJ, Ye K, Boerman OC, Verschueren CM, Dinarello CA, van der Meer JW (1994b) Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. J Immunol 153:5772–5780
Vogels MT, Sweep CG, Hermus AR, van der Meer JW (1992) Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids. Antimicrob Agents Chemother 36:2785–2789
Volk H-D, Reinke P, Krausch D, Zuckermann H, Asadullah K, Müller JM, Döcke W-D, Kox WJ (1996) Monocyte deactivation—rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22:474–481
Volk H-De (1991) Alterations in function and phenotype of monocytes from patients with septic disease—predictive value and new therapeutic strategies. Behring Inst Mitt 88:208–215
Waage A, Bakke O (1988) Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299–302
Wakabayashi G, Cannon JG, Gelfand JA, Clark BD, Aiura K, Burke JF, Wolff SM, Dinarello CA (1994) Altered interleukin-1 and tumor necrosis factor production and secretion during pyrogenic tolerance to LPS in rabbits. Am J Physiol 267:R329–336
Wallach D, Holtmann H, Engelmann H, Nophar Y (1988) Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol 140:2994–2999
West MA, LeMieur T, Clair L, Bellingham J, Rodriguez JL (1997) Protein kinase C regulates macrophage tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 122:204–211; discussion 211–202
West MA, Li MH, Seatter SC, Bubrick MP (1994) Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma 37:82–89; discussion 89–90
Williams Z, Hertogs CF, Pluznik DH (1983) Use of mice tolerant to lipopolysaccharide to demonstrate requirement of cooperation between macrophages and lymphocytes to generate lipopolysaccharide-induced colony-stimulating factor in vivo. Infect Immun 41:1–5
Wilson CS, Seatter SC, Rodriguez JL, Bellingham J, Clair L, West MA (1997) In vivo endotoxin tolerance: impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but nos SIRS. J Surg Res 69:101–106
Wise WC, Cook JA, Halushka PV (1983) Arachidonic acid metabolism in endotoxin tolerance. Adv Shock Res 10:131–142
Wittmann M, Larsson VA, Schmidt P, Begemann G, Kapp A, Werfel T (1999) Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide. Blood 94:1717–1726
Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218–223
Yamamoto C, Yoshida S, Taniguchi H, Qin MH, Miyamoto H, Mizuguchi Y (1993) Lipopolysaccharide and granulocyte colony-stimulating factor delay neutrophil apoptosis and ingestion by guinea pig macrophages. Infect Immun 61:1972–1979
Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ (1998) Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284–288
Yao Z, Foster PA, Gross GJ (1994) Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock 43:107–114
Young HA, Hardy KJ (1995) Role of interferon-gamma in immune cell regulation. J Leukoc Biol 58:373–381
Yoza B, LaRue K, McCall C (1998) Molecular mechanisms responsible, for endotoxin tolerance. Prog Clin Biol Res 397:209–215
Yoza BK, Hu JY, Cousart SL, McCall CE (2000) Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock 13:236–243
Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M (1999) Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274:7611–7614
Zhang X, Morrison DC (1993) Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J Exp Med 177:511–516
Ziegler-Heitbrock HW, Blumenstein M, Kafferlein E, Kieper D, Petersmann I, Endres S, Flegel WA, Northoff H, Riethmuller G, Haas JG (1992) In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75:264–268
Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269:17001–17004
Ziegler-Heitbrock HWL, Frankenberger M, Wedel A (1995) Tolerance to lipopolysaccharide in human monocytes. Immunobiol 193:217–223
Zingarelli B, Chen H, Caputi AP, Halushka PV, Cook JA (1995a) Reorientation of macrophage mediator production in endotoxin tolerance. Prog Clin Biol Res 392:529–537
Zingarelli B, Halushka PV, Caputi AP, Cook JA (1995b) Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 3:102–108
Zuckerman SH, Evans GF (1992) Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol 140:513–519
Zuckerman SH, Evans GF, Butler LD (1991) Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun 59:2774–2780
Zuckerman SH, Evans GF, Snyder YM, Roeder WD (1989) Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J Immunol 143:1223–1227
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag
About this chapter
Cite this chapter
Lehner, M.D., Hartung, T. (2002). Endotoxin tolerance — Mechanisms and beneficial effects in bacterial infection. In: Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology, vol 144. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0116586
Download citation
DOI: https://doi.org/10.1007/BFb0116586
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42814-5
Online ISBN: 978-3-540-45534-9
eBook Packages: Springer Book Archive